Crossref
Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine
Journal of Parathyroid Disease · 2017
DOI: 10.15171/jpd.2018.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parathyroid Disease, 2017. Verfasst von Somayeh Kaviyani und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kaviyani, S., Bahadoram, M., Houshmand, G., & Bahadoram, S. (2017). Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine. Journal of Parathyroid Disease. https://doi.org/10.15171/jpd.2018.07
Vancouver
Kaviyani S, Bahadoram M, Houshmand G, Bahadoram S. Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine. Journal of Parathyroid Disease. 2017. doi:10.15171/jpd.2018.07
BibTeX
@article{Kaviyani2017,
author = {Kaviyani, Somayeh and Bahadoram, Mohammad and Houshmand, Gholamreza and Bahadoram, Samaneh},
title = {Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine},
journal = {Journal of Parathyroid Disease},
year = {2017},
doi = {10.15171/jpd.2018.07}
}
EUVIMED